Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.
The Times Mirror Company; Los Angeles Times - May 11, 1994, Wednesday, Orange County Edition SECTION: METRO; PAGE: B-4
Kevin Johnson and Leslie Berkman; Times Staff Writers
The new funding will extend the drug distribution program through September and pay for 13 new drugs that will be added to the list of medications made available to poor residents with HIV or AIDS.
"Patients all across the county are grateful for the state AIDS drug program," said Dr. Jody Meador, the county's HIV medical director. "A lot of insurance plans don't have prescription coverage or a deductible or make it very difficult for anybody to access expensive medication on a regular basis."
The program, administered by the state Department of Health Services, has allocated more than $2.4 million to AIDS-fighting drugs to Orange County since 1992. Meador said the available medications treat the complications of HIV infections and are used in an attempt to halt or slow the AIDS virus.
Eligible patients receive an identification card after showing county officials they have no means to pay for required treatments. The special identification allows patients to fill their physicians' prescriptions at Sav-On pharmacies without charge.
To receive the drug at no cost, patients must earn $29,444 or less annually. Patients who earn $29,445 to $50,000 are placed on a sliding-scale payment plan.
The state program is "a wonderful service," Meador said. "When you get into the later stages of the disease, the medications can run thousands of dollars a month."
State funding for AIDS treatment for the poor began in 1987 with AZT and today there are 26 drugs, including AZT, available through the state program. The effectiveness of AZT is a subject of debate among researchers.
Dr. Robert Taylor, the county's manager of sexually transmitted diseases and HIV services, said about 200 new patients were approved to receive the drugs in Orange County last year. A total of about 1,500 patients receive the drug assistance annually.
AZT is the most widely prescribed anti-AIDS drug. Several studies have shown that taking AZT after infection but before the onset of symptoms delays progression of the disease. But a study presented last year at the international AIDS conference in Berlin questioned the long-term benefits of the drug's use.
The study, known as Concorde, showed that patients who took AZT early lived no longer than those who used the drug after developing the symptoms of AIDS.
Dr. Peter Kerndt, director of Los Angeles County's HIV epidemiology program, said the drug's availability through the state program has been "better than having nothing at all."
"The exact efficacy of the drug is a matter of debate," Kerndt said, "but I would be taking the drug if I was HIV-positive."
Priscilla Munro, executive director of Orange County's AIDS Services Foundation, said hundreds of the foundation's 611 clients use AZT and many have reported various successes.
"AZT still has its place in the armament," Munro said. "It still is a first-line drug."
940511
LT940502
Copyright © 1994 - Los Angeles Times. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Los Angeles Times, Permissions, Times Mirror Square, Los Angeles, CA 90053. http://www.latimes.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .